India, June 20 -- After months of disruption caused by the Centre halting the supply of life-saving anti-haemophilic factors (AHFs), the Maharashtra government has sanctioned Rs.45 crore for the urgent procurement of clotting factor injections used in the treatment of haemophilia.

This includes Factor VII and Factor VIII (both plasma-derived and recombinant forms), Factor IX, and FEIBA (Anti-Inhibitor Coagulant Complex). These essential drugs are critical for preventing fatal bleeds in patients with haemophilia, a rare genetic blood-clotting disorder.

An AHF is a protein naturally produced in the human body that plays a crucial role in blood clotting.

The state's approval, formalised in a government resolution dated June 18, covers the...